Particle.news

Oura Files S‑1 to List on Nasdaq

The filing spotlights rapid revenue growth, a vast longitudinal biometric dataset and recent accounting volatility that will shape investor scrutiny.

Overview

  • Oura submitted its public S‑1 on Thursday seeking a Nasdaq listing under the ticker OURA and has indicated it may seek up to $3 billion in proceeds with press estimates putting a possible IPO valuation above $16 billion.
  • The company reported strong top‑line growth in the filing, citing roughly $1.4 billion in revenue for the year ended June and $1.21 billion for the nine months ending June, while showing a $59 million net profit for the year and a $924.3 million nine‑month loss largely caused by a deemed dividend on preferred stock.
  • Oura says it sold about 3.6 million rings over the past year and now has approximately 5 million paid members, with an about 85% weighted‑average 12‑month membership retention rate and hardware making roughly 80% of recent revenue versus about 20% from a $6‑per‑month subscription.
  • The filing highlights nearly 42 billion hours of longitudinal biometric data that Oura plans to use for AI features and clinical integrations, but the company also disclosed a proposed class‑action lawsuit alleging its sleep‑stage claims are misleading and named major underwriters for the offering.
  • Investors will weigh Oura’s data and AI strategy against accounting complexity, pending litigation and rising competition from Whoop, Samsung and Google/ Fitbit as the IPO moves to SEC review and market pricing.